(Q33193564)

23 July 2017

Cell cycle- and activation-dependent regulation of cyclosporin A-induced T cell apoptosis (English)

1 reference

23 July 2017

1 reference

ChEBI release 2020-05-28

ChEBI ID

4031

lymphocyte activation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14521916

16 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

16 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

16 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

16 March 2024

5

Gerhard Opelz

1 reference

23 July 2017

4

Mahmoud Sadeghi

1 reference

23 July 2017

Cord Naujokat

1

1 reference

23 July 2017

Volker Daniel

2

1 reference

23 July 2017

Thomas M. Bauer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14521916

16 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

23 July 2017

17 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14521916

full work available at URL

16 March 2024

https://api.elsevier.com/content/article/PII:S0006291X03017972?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

https://api.elsevier.com/content/article/PII:S0006291X03017972?httpAccept=text/plain

16 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Biochemical and Biophysical Research Communications

16 March 2024

published in

1 reference

23 July 2017

310

1 reference

23 July 2017

2

1 reference

23 July 2017

347-354

1 reference

Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders

23 July 2017

1

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology.

16 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Cyclosporine and long-term kidney graft survival

16 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Mechanisms of action of cyclosporine.

16 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Calcineurin: form and function

16 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Transcription factors of the NFAT family: regulation and function

16 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-kappaB activation.

16 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

16 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Role and function of the 26S proteasome in proliferation and apoptosis.

16 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

On the role of proteasomes in cell biology and proteasome inhibition as a novel frontier in the development of immunosuppressants

16 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

A proteasome inhibitor effectively prevents mouse heart allograft rejection

16 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis

16 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

In vitro and in vivo correlation of cyclosporin A-induced apoptosis in acute lymphoblastic leukemia

16 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Proteasome inhibitors induced caspase-dependent apoptosis and accumulation of p21WAF1/Cip1 in human immature leukemic cells.

16 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs

16 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells

16 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation

16 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression

16 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Proteasome regulation of activation-induced T cell death

16 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Proteasome inhibitors block Ras/ERK signaling pathway resulting in the downregulation of Fas ligand expression during activation-induced cell death in T cells

16 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells

16 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

CD69 and regulation of the immune function

16 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

A novel functional interaction between Vav and PKCtheta is required for TCR-induced T cell activation.

16 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin

16 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506.

16 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance.

16 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance

16 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

The biochemistry of apoptosis

16 March 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

The role of CD95 in the regulation of peripheral T-cell apoptosis

16 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

p27Kip1 overexpression causes apoptotic death of mammalian cells

16 March 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

16 March 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Processing/activation of at least four interleukin-1beta converting enzyme-like proteases occurs during the execution phase of apoptosis in human monocytic tumor cells

16 March 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

16 March 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells

16 March 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Tumor necrosis factor-alpha and interferon-gamma induce expression of functional Fas ligand on HT29 and MCF7 adenocarcinoma cells.

16 March 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Mechanisms of caspase activation and inhibition during apoptosis

16 March 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Inducible p27(Kip1) expression inhibits proliferation of K562 cells and protects against apoptosis induction by proteasome inhibitors

16 March 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Translational control of p27Kip1 accumulation during the cell cycle

16 March 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin

16 March 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.141

16 March 2024

Identifiers

1 reference

23 July 2017

1 reference